ABSTRACT The functional coupling of residues that are far apart in space is the quintessential property of allosteric proteins. For example, in Cys-loop receptors, the gating of an intrinsic ion channel is allosterically regulated by the binding of small molecule neurotransmitters 50-60 Å from the channel gate. Some residues near the binding site must have as their primary function the communication of the binding event to the gating region. These gating pathway residues are essential to function, but their identification and characterization can be challenging. This work introduces a simple strategy, derived from mutant cycle analysis, for identifying gating pathway residues using macroscopic measurements alone. In the exemplar Cys-loop receptor, the nicotinic acetylcholine receptor, a well-characterized reporter mutation (bL9 0 S) known to impact gating, was combined with mutations of target residues in the ligand-binding domain hypothesized or previously found to be functionally significant. A mutant cycle analysis of the macroscopic EC 50 measurements can then provide insights into the role of the target residue. This new method, elucidating long-range functional coupling in allosteric receptors, can be applied to several reporter mutations in a wide variety of receptors to identify previously characterized and novel mutations that impact the gating pathway. We support our interpretation of macroscopic data with single-channel studies. Elucidating long-range functional coupling in allosteric receptors should be broadly applicable to determining functional roles of residues in allosteric receptors.
INTRODUCTION
Cys-loop receptors mediate fast synaptic transmission throughout the central and peripheral nervous systems (1) (2) (3) (4) . These pentameric, ligand-gated ion channels are prototypical allosteric receptors (5) , in that the activation (gating) of an intrinsic ion channel is allosterically regulated by the binding of small molecule neurotransmitters (acetylcholine (ACh), serotonin, GABA, or glycine). Although valuable structural insights for Cys-loop receptors have appeared in recent years (6, 7) , detailed conformational mechanisms linking neurotransmitter binding to channel gating remain elusive.
Structurally, Cys-loop receptors have two principal functional domains (Fig. 1) . The extracellular domain, rich in b-sheet structure, contains the agonist binding sites. Each subunit also contains a transmembrane domain comprised of four membrane-spanning helices, one of which (M2) lines the ion channel. Although the precise location of the channel gate has been debated, the consensus positions it at or below the middle of the M2 helix. This puts the channel gate 50-60 Å away from the agonist binding sites. Neurotransmitter binding events must therefore be communicated over this distance to the channel gate.
In terms of function, such a clear demarcation of domains is less evident. For a given residue, if a mutation at the site leads to a change in receptor function, this could be because the binding of agonist or the gating of the channel (or both) has changed. It seems safe to say that residues in the middle of the transmembrane domain do not contribute directly to agonist binding, and so residues in the transmembrane domain that contribute to function are typically described as ''gating'' residues. In contrast, one expects to find residues in the extracellular domain with varying functional roles. Some residues will primarily facilitate agonist binding, either by directly contacting the agonist or by refining the shape or electronic properties of the agonist binding site. However, to achieve the long-range communication that is fundamental to Cys-loop receptor function, other extracellular domain residues must be involved in communicating the binding event to the channel gate, serving an instrumental role in the gating pathway. These gating pathway residues are in some ways the most interesting, but their identification and characterization can be challenging.
One strategy for determining whether a given residue primarily contributes to agonist binding or channel gating involves single-channel recording on appropriate mutants, followed by kinetic analysis. However, in some Cys-loop receptors (such as 5-HT 3 (8) ), single-channel conductances are too small for reliable kinetic analyses (9, 10) ; in many other Cys-loop receptors, single-channel kinetics are complex or nonstationary, again vitiating single-channel kinetic analysis (11, 12) . Also, in other ion channels (13) and in allosteric receptors in general, single-channel studies are often not possible.
A more broadly applicable approach, allowing one to efficiently evaluate a number of mutants in search of unusual behavior, is to measure macroscopic currents across multiple concentrations. This produces the EC 50 value, the concentration that induces half-maximal current in response to applied agonist, along with comparative measurements of maximal agonist-induced currents. In the case of ligand-gated ion channels, EC 50 is a composite value, being responsive to both changes in agonist binding and channel gating behaviors. As such, it can be challenging to interpret shifts in EC 50 . Here we describe an approach to use the readily obtained EC 50 values to identify residues that substantially impact receptor gating. We refer to the method as ELFCAR (elucidating long-range functional coupling of allosteric receptors). The basic tool involves mutant cycle analysis of EC 50 values for distant pairs of mutation sites. Complementary observations concerning mutational effects on receptor efficacy and the effects of partial agonists (PAs) support the basic methodology. Thus, ELFCAR provides an efficient strategy for identification of key gating pathway residues that may otherwise evade detection, without performing single-channel studies.
Key to the approach is the definitive feature of allosteric proteins: action at a distance. When a mutation in the transmembrane domain that is unambiguously associated with channel gating is paired with various mutations in the extracellular domain, the observation of nonmultiplicative EC 50 shifts for the two mutations signals a functional coupling between the two residues, and thus identifies the extracellular domain mutation as influencing gating. We show that this behavior derives from the typical allosteric kinetic scheme for Cys-loop receptors, suggesting the approach could provide a general probe of allosteric receptors.
METHODS

Site-directed mutagenesis
Fetal mouse muscle nicotinic ACh receptor (nAChR) a-, b-, g-, d-subunits were utilized in the experiments. Each subunit was expressed in pAMV vectors. Mutations were made at the site of interest using a standard Stratagene QuikChange protocol. For the incorporation of unnatural residues, the site of interest was mutated to the amber stop codon. In addition, the a-subunits contain an HA epitope in the M3-M4 cytoplasmic loop for Western blot studies. Control experiments show that this epitope does not detectably alter EC 50 . Primers were designed to fulfill the established criteria and were ordered from integral DNA technologies. Polymerase chain reaction (PCR) reactions were carried out using a high-fidelity Pfu DNA polymerase, and a 10 min extension time was used in each thermocycle. Annealing temperatures were modified as required for successful incorporation of the mutation. DpN1 digestion was used to eliminate methylated template DNA from the PCR products. After PCR purification (Qiagen standard protocol), amplification of the PCR product was conducted by electroporation with Super Competent Top 10 Escherichia coli followed by 12 h of growth on agar/Luria broth/ampicillin plates. Single colonies were selected and amplified in liquid Luria broth/ampicillin culture. The DNA was isolated from the bacteria (Qiagen, miniprep kit) and sequenced to verify the successful incorporation of the mutation at the selected site.
The circular bacterial plasmid of the mutation-containing DNA was linearized using a Not1 restriction enzyme. Linearized plasmids were used as the DNA template for in vitro transcription using T7 mMessage mMachine enzyme kits (Ambion) to make mRNA. Quantification of mRNA was determined using a NanoDrop spectrophotometer (NanoDrop Technologies, Thermo Scientific, Wilmington, DE).
For conventional mutations, the stoichiometry of subunits was 2:1:1:1 of a/b/g/d by mass with a total mRNA concentration of~2 mg/mL. For unnatural mutations (14) , a total of 40 ng of mRNA in a 10:1:1:1 a/b/g/d-subunit was coinjected with the synthetic a-hydroxy acids conjugated to the dinucleotide dCA and ligated to truncated 74-nucleotide tRNA as previously described. mRNA/tRNA were typically 1:1.
Stage V-VI oocytes of Xenopus laevis (Nasco, Fort Atkinson, WI) were injected with 50 nL of the mRNA or mRNA/tRNA mixture. The oocytes were incubated in culture media containing 1-2% horse serum at 18 C.
Instruments, Union City, CA). Oocytes were superfused with Ca 2þ -free ND96 solution (in mM: 96 NaCl, 2 KCl, 1 MgCl 2 , 5 HEPES) at flow rates of 4 mL/ min during drug application (15 s) and 3 mL/min during wash (130 s). Macroscopic agonist-induced currents were recorded in response to bath application of the indicated agonist concentrations at À60 mV or À80 mV. Data were sampled at 125 Hz and filtered at 50 Hz. ACh chloride and succinylcholine (SuCh) chloride were purchased from Sigma/Aldrich/RBI (St. Louis, MO). Agonist solutions ranging from 0.0100 mM to 5000 mM were prepared in Ca 2þ -free ND96 from a 1 M stock solution. Dose-response relations were constructed for each mutation using data from R5 oocytes. Dose-response relations were fitted to the Hill equation (Eq. 1) to determine the EC 50 and the Hill coefficient:
where I is the current for agonist concentration [A], I max is the maximum current, EC 50 is the concentration to elicit half maximal response, and n H is the Hill coefficient. The dose-response relations of individual oocytes were examined and used to determine outliers. The reported EC 50 values are from the curve fit of the averaged data.
Single-channel characterization of selected gating pathway residue mutants
Single-channel recording was performed in the cell-attached configuration on devitellinized oocytes 24-60 h after injection at 20 AE 3 C with an applied pipette potential of þ100 mV, as described previously (15) . Pipettes were fabricated from thick-walled (inner diameter ¼ 0.80 mm, outer diameter ¼ 1.60 mm) KG-33 glass (Garner Glass, Claremont, CA) and coated with Sylgard (World Precision Instruments, Sarasota, FL); they had resistances of 8-25 MU. The bath solution contained, in mM, 120 KCl, 5 HEPES, 1 MgCl 2 , 2 CaCl 2 , pH ¼ 7.4, so that the transmembrane potential of the patch was À100 mV, and the reversal potential for agonist-induced currents was~0 mV. The pipette solution contained, in mM, 100 KCl, 10 HEPES, 1 MgCl 2 , 10 K 2 EGTA, pH ¼ 7.4 and was supplemented with the indicated concentrations of ACh using a 1 M stock solution.
Before single-channel recording, whole-cell expression levels were determined with 100-1000 mM ACh doses using the whole-cell recording conditions on each mutant. When whole-cell expression exceeded~300 nA for receptors with the target mutation alone and~3 mA for receptors with a target mutation and a reporter mutation, oocytes were typically incubated 4-10 additional h before single-channel recording. Data were collected using a GeneClamp 500B amplifier (Axon Instruments, Union City, CA) with a CV-5 100 GU headstage at full bandwidth (4-pole Bessel, À3 dB, 50 kHz). The signal was then low-pass filtered (8-pole Bessel, À3 dB, 20 kHz) and sampled with a Digidata 1320A and Clampex 9.2 (Axon Instruments, Union City, CA) at 50 or 100 kHz. Only recordings that showed no simultaneous activations were included in NP open analysis. In this manner, Rthree patches at EC 50 were analyzed for all mutants, except for the abgD174NdD180N and abL9 0 S gD174NdD180N mutants for which two patches each were obtained. Data were filtered offline (Gaussian, À3 dB, 5 kHz) and electrical interference at harmonics of 60 Hz was removed, if necessary. Event transitions were detected with Clampfit 9.2 (single-channel search). A dead time, 
RESULTS
The prototypical and most-studied Cys-loop receptor, the muscle nicotinic ACh receptor (nAChR), was used in this study. It is important to appreciate that the method is directly applicable to other Cys-loop receptors, and, in favorable cases, to other allosteric proteins as well. Here we have employed the muscle-type nAChR as a well-established system that allows us to evaluate the methodology.
The muscle nAChR is a heteropentamer with subunit composition (a1) 2 b1gd. Two nonequivalent binding sites are located in the extracellular domain at the aÀd and aÀg-subunit interfaces. Nearly all Cys-loop receptors, including all nAChRs, contain a conserved leucine residue in the hydrophobic, pore-lining M2 helix of each subunit (Fig. 1) . Mutating this residue, termed L9 0 , to serine lowers the EC 50 (16, 17) . Structural studies place L9 0 near the middle of the M2 helix, in the region of the occlusion of the closed channel, and although it can be debated whether L9 0 constitutes a literal gate of the channel, there can be no doubt that it is a crucial gating residue. In this work, the L9 0 S mutation in the b-subunit was used as a reporter to evaluate mutations of residues in the extracellular domain that may function as binding residues or as gating pathway residues.
bL9
0 S as a reporter of functional role for extracellular residues Agonist occupancy at both binding sites is required for efficient opening of the channel pore. Scheme 1 shows a simplified kinetic model for activating the nAChR, leading to an expression for EC 50 (Eq. 2) (18, 19) , where A is the agonist; R C and R O denote the closed and open states of the receptor; k 1 and k -1 are forward and reverse rate constants for agonist binding; K D is the dissociation constant for the agonist; and Q is the gating equilibrium constant, given by the ratio of the channel opening rate, b, to the channel closing rate, a. It is well understood that the actual kinetic model for the nAChR is likely more complicated, and that different Cys-loop receptors may show kinetic schemes that differ in detail. In addition, a strong gating mutation could enable spontaneous openings of the channel when no agonist is bound. This could compromise the kinetic model discussed here. However, the bL9 0 S mutation alone does not lead to extensive spontaneous openings, and the types of mutations emphasized here, if they impact gating at all, discourage channel opening (decrease Q), suggesting that spontaneous openings will not produce a major perturbation to the system. Scheme 1 is typical for an allosteric receptor, capturing the essence of the situation: function depends on binding of an allosteric effector as well as signal transduction (gating). For ligand-gated ion channels, this means that EC 50 depends on K D and Q, where Q is a measure of receptor efficacy. The graphical representation of the relationship between EC 50 and Q, based on Eq. 2, is shown in Fig. 2 . Simulations of more-complex kinetic schemes produce qualitatively similar plots. For full agonists (FAs), that is, those that produce a large Q, the plot is linear with a negative slope. We will refer to this as the ''high slope'' region of the plot. For smaller values of Q, such as would be associated with partial agonism, the plot approaches an asymptote. We will refer to this as the ''plateau'' region:
where
A defining feature of allosteric proteins is that an allosteric effector shifts the equilibrium between two states, historically termed tensed and relaxed. However, binding of the allosteric effector itself does not define the exact state as tensed or relaxed, rather it produces a shift in the equilibrium distribution between these states. Consequently, once the allosteric signal is saturated, this equilibrium distribution depends only on the equilibrium constant governing tensed-relaxed interconversion. In the case of ligand-gated ion channels, such as the nAChR studied here, different allosteric effectors-i.e., different ligands for ligand-gated ion channels-produce different closed-open equilibria, characterized by Q. Thus, whereas FAs (Q >> 1) cause the channel to be mostly open when agonist is bound, PAs influence this allosteric transition to a lesser extent, resulting in a smaller perturbation of the gating equilibrium. It is the varying extent to which ligand binding can bias the equilibrium that produces the general shape of the relationship between EC 50 (function) and Q, seen in Fig. 2 . Previous studies (17, (20) (21) (22) have shown that polar mutations at L9 0 substantially increase Q, causing a corresponding drop in EC 50 . Our goal was to determine whether it was possible to use a reporter mutation such as bL9 0 S to evaluate whether the shift in EC 50 from mutation at a target residue is primarily a result of changes in binding (K D ) or gating (Q) (see the Supporting Material, Fig. S1 ). Consider such a target mutation in the extracellular domain that only increases K D , i.e., a pure binding mutation. This has the effect of raising the EC 50 versus Q curve, but maintaining its shape (Fig. 2, red  line) . Addition of the bL9 0 S mutation then causes a comparable increase in Q, lowering EC 50 by the same factor as in the wild-type. The pairing of an extracellular domain binding mutation with the reporter transmembrane domain mutation results in a multiplicative shift in EC 50 ; the two mutations are independent. Now, consider the consequences of an extracellular domain target mutation that affects gating, and not binding. Deleterious mutations (increase in EC 50 ) will cause a drop in Q, and if the effect is large enough, the agonist employed will now be a PA. The EC 50 versus Q relationship for this mutant will now lie in the plateau region of Fig. 2 . As a result, the subsequent increase in Q caused by adding the bL9 0 S mutation will induce a much smaller drop in EC 50 . The pairing of these mutations will no longer give a multiplicative shift in EC 50 , and therefore the two mutations are functionally coupled. Thus, the bL9 0 S gating mutation acts as a reporter to identify a target mutation that is substantially loss of function (decreasing Q). It is clear from Fig. 2 that a gain-of-function gating mutation (lower EC 50 ; increasing Q) will still be in the high slope region and so will be additive with the bL9 0 S mutation. This method cannot detect gain-of-function gating mutations.
For many mutations in the extracellular domain, the bL9 0 S mutation is multiplicative, producing a consistent 40-fold shift to lower EC 50 (Table 1) (17, 23, 24) . We now report the first examples of mutations closely associated with the agonist binding site for which the effect of bL9 0 S is substantially <40-fold, indicating nonmultiplicative behavior (Fig. 1) . Four of these are conventional mutants: aY190F, gD174NdD180N, gW55YdW57Y, and aD200N. Others have probed these sites, and they are generally considered to primarily influence gating (25) (26) (27) (28) (29) (30) (31) . As such, these studies validate the ELFCAR method. The fifth, a novel mutant, replaces aS191 with its a-hydroxy analog, which we abbreviate Sah (for serine a-hydroxy), converting the backbone amide that links aY190 and aS191 to a backbone ester (32, 33) .
Mutant cycle analysis suggests long-range coupling
The typical way to analyze a system in which two mutations are evaluated, individually and in tandem, is by mutant cycle analysis (Fig. 3) . Briefly, if a mutation at one site has no structural or energetic impact at a second site, then the effect of simultaneous mutations at both sites will simply be multiplicative (Fig. 3) . In the parlance of mutant cycle analysis, the coupling parameter, U, will be unity. In contrast, if two residues interact, the simultaneous mutation at both sites will lead to an effect that is either greater or less than the product of their individual effects, producing an U-value 50 , as shown when the reporter effect is added to the wild-type receptor. However, when beginning with Q in the plateau region, a much smaller shift in EC 50 occurs for equivalent shifts in Q.
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As could be anticipated from the EC 50 values in Table 1 , the majority of mutations made in the extracellular domain of the nAChR produce an U for coupling to bL9 0 S of~1, indicating the functional independence of these residues. However, the five mutations noted above-aY190F, gD174NdD180N, gW55YdW57Y, aD200N, and aS191Sah-produced larger U-values. We consider a value of U > 2 to signify a meaningful coupling (Fig. 4) . Phenomenologically, this establishes a long-range coupling between these extracellular domain sites and the bL9 0 site, as one would expect for an allosteric receptor. Typically, an U that deviates significantly from a value of 1 is interpreted to indicate a direct interaction between the residues, such as a hydrogen bond or a salt bridge. In this work, though, such a direct interaction is clearly impossible. We feel the interpretation of Fig. 2 is much more palatable. Significant coupling is seen because both the bL9 0 S mutation and the particular extracellular domain mutation disrupt the gating pathway.
Single-channel recording supports whole-cell mutant cycle analysis conclusions
The most convincing way to evaluate the impact of a particularly interesting mutation is by single-channel analysis. To test our interpretation of the mutant cycle analyses using EC 50 values, we chose three extracellular domain mutants that ELFCAR identified as gating pathway residues (aY190F, gD174NdD180N, and gW55YdW57Y) for single-channel studies. From these recordings, the open probability in the patch, NP open was obtained. N is the number of channels in the patch, which often cannot be precisely determined. P open is derived from Scheme 1 and Values for the three coupled residues are also given for reporter mutations in all other subunits (g, d, and a) and positions (9 0 , 13 0 , and 16 0 ). The ratio of EC 50 s: target/target with reporter, and resultant calculated U-values are also reported. The standard error for all EC 50 values was <10%, except for *, which had standard error of 20%. Data at sites a148(51), a149 (24) , and aS191(47) have been reported previously. Table 2 ) compared to the wild-type value of~0.5 (data not shown); they are substantially deleterious gating pathway mutations. Also consistent with the model, adding the bL9 0 S mutation substantially increases NP open . The single-channel analysis thus supports the interpretation of the macroscopic EC 50 data.
Other reporter mutations support gating pathway assignments
An implication of this experimental strategy is that other residues in the transmembrane domain that substantially increase Q could act as reporters for extracellular domain residues; we are not limited to the b-subunit or the well-characterized L9 0 position. To test this notion, L9 0 S mutations were made in the a-, g-, and d-subunits, and two other Ser mutations were made in the M2 helix of the a-subunit at positions V13 0 and L16 0 (Fig. 1) . All of these mutations lower EC 50 significantly, and all positions are confidently ascribed to be gating residues. As shown in Fig. 6 , the extracellular domain mutations that give significant U-values with bL9 0 S also show significant U-values with L9 0 S mutations present in the other subunits. Recalling that there are two a-subunits, we find a general coupling parameter sequence of b z d > a > g. Thus, subtle asymmetries between subunits exist regarding the L9 0 residues' contribution to gating, which are also reflected in the EC 50 values of the various L9 0 S mutants (Table 1) . If one considers positions other than 9 0 , all the mutated gating pathway residues again produce meaningful U-values, and the magnitude of their effect is consistently a9 0 > a16 0 > a13 0 (Fig. 6 ).
The reporter mutation bL9 0 S systematically increases I max for gating pathway residues This interpretation of the mutant cycle analysis data predicts other behaviors for extracellular gating pathway residues.
For example, to produce a significant mutant cycle analysis coupling to L9 0 (U >2), the mutation in the extracellular domain must convert ACh to a PA, such that the target mutation is now in the plateau region of Fig. 2 . Due to this decrease in Q, the maximal current observed in response to saturating concentrations of ACh (I max ) should diminish. In general, interpreting differences in I max can be challenging due to variations in whole-cell current among oocytes, which can stem from various sources that may or may not relate to the actual mutation in question. However, use of a reporter mutation can assist in the interpretation of I max differences. For mutations that render ACh a PA, increasing efficacy through a reporter mutation produces a significant systematic increase in I max (Fig. S2) . We find that these increases are larger and more consistent than the typical variability in I max in conventional mutagenesis studies. Thus, if a receptor with a target mutation shows a large increase in mean I max on introduction of a reporter mutation, the mutation likely affects gating. This is shown in Fig. 7 for mutations with large U-values, along with several examples with U near one. Recovery of I max by introduction of the reporter mutation confirms the gating pathway residue assignments made by mutant cycle analysis. Moreover, the single-channel observations support this interpretation, in that the increase in NP open is the microscopic correlate of the macroscopic observation of recovery of I max ( Table 2 ; the quantitative differences between U, I max , and NP open are considered in the Supporting Material).
Experiments with the PA SuCh support gating pathway assignments
Given the argument that a substantially deleterious mutation of a gating pathway residue converts the FA ACh to a PA, which manifests as a diminished I max , it is interesting to consider the behavior of an inherent PA, such as SuCh (37) . The relative efficacy, 3, of a PA can be defined as the ratio of the maximal current elicited by a PA to the maximal current elicited by a FA (Eq. 3). At saturating doses of FIGURE 4 Values of U (coupling to bL9 0 S) for mutations considered here. The standard 40-fold shift expected for a bL9 0 S mutation produces an U-value of one (horizontal line). 5-F-Trp is 5-fluorotryptophan and 5-Br-Trp is 5-bromotryptophan. For a-hydroxy acids (Yah, Nah, Lah, Tah, Wah, Vah, Iah, and Aah), a three-letter abbreviation is used: the one-letter code for the parent amino acid is followed by ah; thus Yah is the a-hydroxy acid of tyrosine.
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Long-Range Coupling in Receptorsagonist, all the receptors are presumed to be in a diliganded state (A 2 R), meaning that differences in I max for the two agonists are due to differences in the probability that a single channel is open when the binding equilibrium is saturated, P open,max . For wild-type muscle nAChR, SuCh is a PA with~4% efficacy relative to ACh. 
In the presence of an L9 0 S mutation alone, SuCh becomes a FA (see Fig. S3 ). Three of the five gating pathway residues were characterized using the PA SuCh. Unlike what is observed for binding mutations, when aY190F, gD174NdD180N, and gW55YdW57Y contained a L/S mutation at either the 9 0 (a or b), 13 0 (a), or 16 0 (a) site, the recovery of SuCh toward full agonism is blocked. As before, the magnitude of the effect follows the trend a9 0 > a16 0 > a13 0 (data not shown). This is interpreted as further evidence that mutation of these extracellular domain residues drastically impairs normal gating function. Note that the efficacies of SuCh for the gating pathway mutants without the L9 0 S reporter mutation are not dramatically different from that of wild-type (0.04 AE 0.02 for wild-type, 0.04 AE 0.01 for aY190F, 0.02 AE 0.01 for gD174NdD180N, and 0.01 AE 0.0009 for gW55YdW57Y). This again highlights how the use of a reporter mutation can uncover important aspects of receptor function that might otherwise be missed.
DISCUSSION
In this work, we propose that appropriately designed double mutant studies can provide valuable insights into the mechanism of action of an allosteric receptor. We begin with a mutation at a site whose function is unambiguous. Here, this reporter residue can be one of several sites in the transmembrane region of a ligand-gated ion channel, far removed FIGURE 5 Single-channel currents for select mutants. In each case, ACh is applied at the macroscopic EC 50 value (Table 1) , and the left panel has no reporter mutation, whereas the right panel is for receptors with the bL9 0 S reporter mutation. For each of the six receptors, the lower trace (5 s) depicts an expansion of the section of the upper trace indicated with a line. Records were obtained in the cell-attached configuration with a pipette potential of þ100 mV and are shown at 5 kHz bandwidth. Channel openings are shown as downward deflections. (A) aY190F; (B) gD174NdD180N; and (C) gW55YdW57Y. from the agonist binding site. It is assumed that mutations at this site primarily, if not exclusively, perturb the gating of the receptor, and this view is supported by detailed studies of the reporter mutations. A second site, the target site, can then be probed by combining mutations there with a reporter mutation. Here we consider a number of target sites that are far removed from the reporter residue. Analysis of the results can proceed along several lines. The classical tool is a mutant cycle analysis. Indeed we find that, whereas most pairings of remote residues produce independent behavior (U~1), for select target residues a mutant cycle analysis produces strong coupling parameters. Typically, such coupling is interpreted to indicate a direct interaction between the residues. However, in all cases here, the residues are much too far apart to accommodate a direct structural interaction. As such, we have an allosteric coupling between remote residues, which manifests in a mutant cycle analysis just as if the two were structurally coupled. Of course, such action at a distance is the definitive feature of an allosteric system, but there are few cases where such pairwise interactions have been seen. Because the reporter mutation influences gating, coupling requires that the target residue also impact gating, allowing an apparent long-range interaction to be revealed in the mutant cycle analysis. We have labeled such residues as being on the ''gating pathway'', with the understanding that any mutation that preferentially stabilizes one state of the receptor could produce a positive result in ELFCAR, regardless of its location in the receptor. The particular residues studied here, however, do lie in regions of the receptor that have been considered to be part of the primary structural transduction from binding site to channel gate. A less-phenomenological analysis can be made with reference to Fig. 2 . The key here is that if the mutation at the target site perturbs gating by decreasing Q, moving the system to the left along the EC 50 versus Q curve, and, if the effect is large enough, the system will now be in the plateau region. Then, when the reporter mutation is added, its effect on EC 50 will be diminished relative to what is seen in the receptor that is wild-type at the target site. To be informative, the mutation at the target site must be loss of function (diminished Q) and must have a substantial effect on gating. If Q is diminished only slightly by the target mutation, or if Q is increased (gain of function) the system will remain in the region of high slope, and the reporter mutation will have its normal effect. Also, when we do see significant coupling, that does not rule out the possibility that K D has changed in addition to Q; ELFCAR can only establish that a significant decrease in Q has occurred. At the same time, when a target mutation produces a large shift in EC 50 but a conventional 40-fold additional shift on adding the bL9 0 S reporter mutation, it is tempting to conclude that the target mutation exclusively impacted K D . However, changes in Q that are significant but not large enough to move the system into the plateau region of Fig. 2 could be involved in addition to or instead of a K D change. For example, the K145Q mutation has been reported to impact gating (28) , but without moving Q into the plateau region.
In this work, K145Q shows a marginal functional coupling with L9 0 S, with an U-value near the cutoff for significance (1.8 AE 0.2). As such, ELFCAR is best suited to identifying mutations that strongly perturb gating (U > 2); negative results should be interpreted cautiously. Note that in receptors for which the wild-type Q is smaller than in the muscle-type nAChR, ELFCAR would be expected to be more sensitive to small changes in Q.
Several additional observations support our analysis of the results seen here. First, in a typical mutant cycle analysis, U-values <1 can be observed and are functionally significant. However, in this context, the model of Fig. 2 allows only for U > 1, which is consistent with our data. Importantly, three mutations shown here to impact gating by the ELFCAR approach have been confirmed to be gating mutations by single-channel analyses. The single-channel values we report are NP open . The true probability that a single channel is open at these concentrations, P open , is increased by a factor of N, where N is the number of channels in the patch. Because the measured probability that the channel is open is low (%2%) for the gating pathway mutations without the reporter mutation, the number of channels in the patch cannot be determined. However, if there are actually multiple channels in these patches, our NP open values would be overestimates of P open .
The measured NP open values are substantially diminished upon addition of each of the three target residues we tested (aY190F, gD174NdD180N, and gW55YdW57Y), such that the modest perturbation of EC 50 associated with the target mutations can be primarily ascribed to dramatic changes in the gating pathway. Other single-channel studies of residues considered here are also consistent with our findings. Other observations support our general model. If a target mutation substantially reduces Q, then ACh should become a PA at the receptor. This should lead to reduced maximal currents from whole-cell recordings, and just such an effect is seen. Also, an inherent PA should be sensitive to the consequences of the target mutation, and we find that is the case for SuCh.
It is interesting to consider the residues that have been probed here; Fig. 1 highlights them all. The considerable distance between the reporter residues and the target residues is clear from this image. Concerning the target residues, those with no strong coupling (purple) are dispersed throughout the extracellular domain, and, although only five have been identified so far, the same is true of the gating pathway residues (orange). There is no simple pattern that distinguishes the two classes.
The agonist binding site of the nAChR is an ''aromatic box'', shaped by five conserved aromatic residues: aY93 (A), aW149 (B), aY190 (C1), aY198 (C2), and gW55/ dW57 (D) (6, 38) . The letter designations signify the ''loop'' of the extracellular domain that contains the particular residue (39) . Because all the natural agonists of Cys-loop receptors have a cationic group, the presence of the aromatic box suggested that a cation-p interaction contributes to agonist binding (40, 41) . Indeed, aW149 (B) and the aligning residues have been shown to contribute to agonist binding through a cation-p interaction in both the nAChR and the 5-HT 3 receptors (24, 42) . We find U~1 consistent with a binding role for this residue. Note that subtle mutations have been employed at this site, taking advantage of the power of unnatural aminoacid mutagenesis. We cannot rule out the possibility that more disruptive mutations at this and other sites would impact receptor gating. Indeed, the aW149F mutation has been probed, and it impacts binding and gating (43) . Most of the mutations in Table 1 are, by conventional standards, subtle, and we would argue that some caution must by employed in interpreting the consequences of more severe mutations.
The residue analogous to aY198 (C2) has been shown to bind serotonin through a cation-p interaction in the MOD-1 receptor (44) . Previous studies in the nAChR show that mutations at this site exhibit normal coupling to L9 0 S mutations (45) . Single-channel studies of the aY198F mutant indicate only modest changes in gating (26) that would be outside the limits of detection for ELFCAR.
The residue aY93 (A) has been extensively probed. In the GABA A receptor the analogous residue makes a cation-p binding interaction to the native agonist (46) . In the nAChR, side-chain mutations at this site strongly impact channel gating. However, the mutation studied here, aY93Yah, is a backbone mutation. Our finding of U~1 indicates no strong perturbation of gating by a backbone mutation in this region. This conclusion is supported by the similar result at the adjacent residue (aN94Nah).
The remaining two box residues, aY190 (C1) and gW55/ dW57 (D), have never been shown to make a cation-p interaction with an agonist. Both are assigned as gating pathway residues according to the ELFCAR method. aY190 has been extensively studied. That aY190F strongly impacts gating is unambiguously established by the single-channel records of Fig. 5 A. Other workers have also found strong perturbations to gating for mutations at this site (27, 28) . Some studies have also found a contribution to binding, but, as discussed above, this work does not address this issue. The important point is that the finding of a large U-value in ELFCAR is supported by single-channel studies. In addition, a backbone mutation at the adjacent residue, aS191Sah, also produces a large U-value in ELFCAR. We have recently shown that this residue makes a strong hydrogen bond to a side chain from the complementary subunit (g/d) and that the hydrogen bond contributes significantly to gating (47) . Most gating models for the nAChR invoke considerable movement of loop C (6, 48, 49) , and the finding of large U-values for these two loop-C residues is consistent with these models.
The final binding box residue, gW55/dW57 (D), shows a large U-value for the Tyr mutant. Our single-channel studies (Fig. 5 C) establish an impact on gating for this mutation. Previous single-channel studies of the Phe mutant show a small effect on binding (3.4-fold) and a large effect on gating (50-fold) (50), consistent with these results. There is reason to anticipate that loop D may also undergo significant rearrangements during gating. In Unwin's image of the Torpedo nAChR (7), with no agonist bound, TrpD is flipped out away from the box that is so well formed in AChBP (with or without agonist bound). This again suggests that movement of TrpD occurs on ligand binding, consistent with it being a gating pathway residue.
The fifth gating pathway residue we identified, aD200, is not part of the aromatic binding box but appears to lie outside the box. However, it is part of a triad of residues that includes aY190 and aK145 and that has been suggested to undergo significant rearrangement on gating (28) . Previous singlechannel studies have shown that mutation at this site perturbs gating (25, 28) . As such, the large U seen here with ELFCAR is consistent with other studies.
CONCLUSIONS
In this work, we have developed an efficient strategy for identifying mutations that impact receptor function by significantly impeding the gating pathway. The method involves combining mutations of extracellular domain residues proposed to be functionally important with a known gating pathway (reporter) mutation. For interesting sites, ELFCAR can provide guidance for more focused, advanced studies, such as detailed unnatural amino acid mutagenesis of putative binding residues or single-channel analysis, where possible, for gating residues.
The kinetic model of Scheme 1 refers to the nAChR, but it contains the essential features of any allosteric system. There is a binding interaction with an allosteric effector and an Biophysical Journal 96(8) 3168-3178 intrinsic conformational change associated with the signaling event. The former is a bimolecular association, and so is saturable at high ligand concentration. However, the conformational change is unimolecular, and so it is an intrinsic property of the system. It is the combination of these two processes that produces the curvature of Fig. 2 and thus allows for the specific application of mutant cycle analysis presented here. As such, we anticipate that the same approach could be applied to other allosteric systems, allowing a facile means to identify the roles of particular residues in a complex protein system. Thus, although this study has focused on a single Cysloop receptor, we believe the approach is broadly applicable to other Cys-loop receptors and to allosteric receptors in general. Certainly, comparable reporter residues can be found in the other Cys-loop receptors; the L9 0 residue is highly conserved and it seems likely to play an important gating role throughout the family. We emphasize that, although all members of the Cys-loop family are genetic orthologs, functional paralogs, and structural homologs, there is growing evidence that the detailed mechanisms of action will vary from system to system (41) . Thus, this approach, based on the readily obtained EC 50 measure, offers a robust and efficient way to search for such variations in gating mechanism.
SUPPORTING MATERIAL
Three figures and supporting text are available at http://www.biophysj.org/ biophysj/supplemental/S0006-3495(09)00477-9.
